Ryota Hase

5PUBLICATIONS
18CO-AUTHORS
Major global burdens of diseaseIntensive careMedical infection agents (incl. prions)Biomedical instrumentationDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan.

|Jan 08, 2026
Clinical characteristics, treatments and outcomes of hospitalised COVID-19 patients across pandemic waves at a tertiary acute care hospital in Narita, Japan: a single-centre retrospective observational study.

Ryota Hase, Rika Kurata, Yu Niiyama

|Jun 06, 2024
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.

Ryota Hase, Aki Sakurai, Masahiro Suzuki

|Jul 24, 2023
Enterobiasis in the hospitalized patient.

Emiri Muranaka, Naoki Okawa, Nobuaki Tsuyama

|Nov 10, 2021
Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review.

Ryota Hase, Yu Niiyama, Haruki Mito

Pageof 1

Frequent Collaborators

2 joint publications

Naoya Itoh

2 joint publications

Kayoko Hayakawa

2 joint publications

Yasufumi Matsumura

2 joint publications

David van Duin